Stay updated on ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial.
Sign up to get notified when there's something new on the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page.

Latest updates to the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference12%
- Check17 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page version updated from v3.0.1 to v3.0.2, signaling a minor update. The 'Back to Top' link was removed, with no other changes to core content such as pricing or stock.SummaryDifference0.7%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.7%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference12%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ENZA-p: Enzalutamide + Lu PSMA-617 vs Enzalutamide Clinical Trial. page.